{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T15:33:22Z","timestamp":1777044802652,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","content-domain":{"domain":["jad-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.jad.2013.12.042","type":"journal-article","created":{"date-parts":[[2014,1,11]],"date-time":"2014-01-11T10:00:53Z","timestamp":1389434453000},"page":"41-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["A preliminary report of increased plasma levels of IL-33 in bipolar disorder: Further evidence of pro-inflammatory status"],"prefix":"10.1016","volume":"157","author":[{"given":"Izabela Guimaraes","family":"Barbosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabela Boechat","family":"Morato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline Silva","family":"de Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mois\u00e9s Evandro","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jair C.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f4nio Lucio","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jad.2013.12.042_bib1","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.4049\/jimmunol.179.4.2051","article-title":"Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells","volume":"179","author":"Allakhverdi","year":"2007","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.jad.2013.12.042_bib2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00406-010-0116-z","article-title":"Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder","volume":"261","author":"Barbosa","year":"2011","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.jad.2013.12.042_bib3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00406-012-0327-6","article-title":"Chemokines in bipolar disorder: trait or state?","volume":"263","author":"Barbosa","year":"2012","journal-title":"Eur. Arch. Psychiatry. Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.jad.2013.12.042_bib4","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.neubiorev.2010.10.001","article-title":"Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors","volume":"35","author":"Berk","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2013.12.042_bib5","first-page":"31","article-title":"An evidence-based medicine strategy for achieving remission in bipolar disorder","volume":"69","author":"Byer","year":"2008","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2013.12.042_bib6","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.clim.2011.11.007","article-title":"Interleukin-33 upregulation in peripheral leukocytes and CNS of multiple sclerosis patients","volume":"142","author":"Christophi","year":"2012","journal-title":"Clin. Immunol."},{"issue":"10","key":"10.1016\/j.jad.2013.12.042_bib8","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1002\/ibd.22900","article-title":"IL-33 attenuates development and perpetuation of chronic intestinal inflammation","volume":"18","author":"Gro\u03b2","year":"2012","journal-title":"Inflamm. Bowel Disord."},{"issue":"3","key":"10.1016\/j.jad.2013.12.042_bib9","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jaci.2012.11.028","article-title":"Decoding asthma: translating genetic variation in IL33 and IL1RL1 into disease pathophysiology","volume":"131","author":"Grotenboer","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jad.2013.12.042_bib10","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","article-title":"Development of a rating scale for primary depressive illness","volume":"6","author":"Hamilton","year":"1976","journal-title":"Br. J. Soc. Clin. Psychol."},{"issue":"5","key":"10.1016\/j.jad.2013.12.042_bib11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12264-011-1025-5","article-title":"Research progress on interleukin-33 and its roles in the central nervous system","volume":"27","author":"Han","year":"2011","journal-title":"Neurosci. Bull."},{"issue":"3","key":"10.1016\/j.jad.2013.12.042_bib12","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1189\/jlb.1207830","article-title":"Induction of IL-33 expression and activity in central nervous system glia","volume":"84","author":"Hudson","year":"2008","journal-title":"J. Leukocyte Biol."},{"issue":"9","key":"10.1016\/j.jad.2013.12.042_bib13","doi-asserted-by":"crossref","first-page":"6941","DOI":"10.1074\/jbc.M111.298703","article-title":"Interleukin 33 as a mechanically responsive cytokine secreted by living cells","volume":"287","author":"Kakkar","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.jad.2013.12.042_bib14","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s11481-013-9439-7","article-title":"Glia maturation factor induces interleukin-33 release from astrocytes: implications for neurodegenerative diseases","volume":"8","author":"Kempuraj","year":"2013","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"10","key":"10.1016\/j.jad.2013.12.042_bib15","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1002\/eji.200737547","article-title":"IL-33 is a chemoattractant for human Th2 cells","volume":"37","author":"Komai-Koma","year":"2007","journal-title":"Eur. J. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.jad.2013.12.042_bib16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jneuroim.2012.05.001","article-title":"Reduced levels of interleukin 33 and increased levels of soluble ST2 in subjects with amyotrophic lateral sclerosis","volume":"249","author":"Lin","year":"2012","journal-title":"J. Neuroimmunol."},{"issue":"1\u20132","key":"10.1016\/j.jad.2013.12.042_bib17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12026-012-8283-9","article-title":"IL-33\/ST2 axis in inflammation and immunopathology","volume":"52","author":"Milovanovic","year":"2012","journal-title":"Immunol. Res."},{"issue":"1","key":"10.1016\/j.jad.2013.12.042_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.biopsych.2013.01.007","article-title":"Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies","volume":"74","author":"Modabbernia","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2013.12.042_bib19","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/rheumatology\/kep402","article-title":"Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus","volume":"49","author":"Mok","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.jad.2013.12.042_bib20","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jpsychires.2013.05.018","article-title":"Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis","volume":"47","author":"Munkholm","year":"2013","journal-title":"J. Psychiatry Res."},{"issue":"10","key":"10.1016\/j.jad.2013.12.042_bib21","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1046\/j.1365-2745.2002.01494.x","article-title":"Expression and function of the ST2 gene in a murine model of allergic airway inflammation","volume":"32","author":"Oshikawa","year":"2002","journal-title":"Clin. Exp. Allergy"},{"issue":"6","key":"10.1016\/j.jad.2013.12.042_bib22","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.neubiorev.2007.04.003","article-title":"Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena","volume":"31","author":"Post","year":"2007","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2013.12.042_bib23","first-page":"4","article-title":"The Mini International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"issue":"8","key":"10.1016\/j.jad.2013.12.042_bib24","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/intimm\/dxn060","article-title":"IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells","volume":"20","author":"Smithgall","year":"2008","journal-title":"Int. Immunol."},{"issue":"2\u20133","key":"10.1016\/j.jad.2013.12.042_bib25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cytogfr.2004.02.004","article-title":"T1\/ST2\u2014an IL-1 receptor-like modulator of immune responses","volume":"15","author":"Trajkovic","year":"2004","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1\u20132","key":"10.1016\/j.jad.2013.12.042_bib26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jad.2011.08.022","article-title":"Inflammatory markers and their relationships with leptin and insulin from acute mania to full remission in bipolar disorder","volume":"136","author":"Tsai","year":"2012","journal-title":"J. Affect. Disord."},{"issue":"8","key":"10.1016\/j.jad.2013.12.042_bib27","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.2310\/JIM.0b013e31826d8fcb","article-title":"IL-33; a potential therapeutic target in autoimmune diseases","volume":"60","author":"Wang","year":"2012","journal-title":"J. Investig. Med."},{"key":"10.1016\/j.jad.2013.12.042_bib28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.brainres.2011.02.045","article-title":"Production and functions of IL-33 in the central nervous system","volume":"1385","author":"Yasuoka","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.jad.2013.12.042_bib29","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032713008951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032713008951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T07:20:29Z","timestamp":1538896829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032713008951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":28,"alternative-id":["S0165032713008951"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2013.12.042","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A preliminary report of increased plasma levels of IL-33 in bipolar disorder: Further evidence of pro-inflammatory status","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2013.12.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}